companydata.dkcompanydata.dk

EUROLYSE IVS: Financial statements 2021

CVR: 36462191

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

EUROLYSE IVS (CVR 36462191) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2021 report amounted to DKK 100. The solvency ratio was 100%.

Revenue
DKK 0
Equity
DKK 100

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021000100-
2020000100-
2019-00100-
2018-00100-
2017-00100-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like EUROLYSE IVS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Lars Mårten Örjan Andersson joins EUROLYSE IVS as liquidatorOct 15, 2021

As of October 15, 2021, Lars Mårten Örjan Andersson is registered as liquidator of EUROLYSE IVS.

Lars Mårten Örjan Andersson steps down as director of EUROLYSE IVSOct 15, 2021

As of October 15, 2021, Lars Mårten Örjan Andersson has stepped down as director of EUROLYSE IVS.

EUROLYSE IVS enters liquidationOct 15, 2021

On October 15, 2021, EUROLYSE IVS entered liquidation.

EUROLYSE IVS: The 2020 annual report is outJul 7, 2021

EUROLYSE IVS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK 0.

About EUROLYSE IVS

EUROLYSE IVS was a Danish company of the type Iværksætterselskab based in Frederikssund, founded in 2014. The company has been dissolved on 22 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CRETECSYS IVS. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 100.

Source: annual report 2024, Danish Business Authority